참고문헌
- Bell R, Brice G, Child AH, et al (2001). Analysis of lymphoedemadistichiasis families for FOXC2 mutations reveals small insertions and deletions throughout the gene. Hum Genet, 108, 546-51. https://doi.org/10.1007/s004390100528
- Benayoun BA, Caburet S, Veitia RA (2011). Forkhead transcription factors: key players in health and disease. Trends Genet, 27, 224-32. https://doi.org/10.1016/j.tig.2011.03.003
- Carlsson P, Mahlapuu M (2002). Forkhead transcription factors: key players in development and metabolism. Dev Biol, 250, 1-23. https://doi.org/10.1006/dbio.2002.0780
- Chen W, Yuan K, Tao ZZ, et al (2011). Deletion of Forkhead Box M1 transcription factor reduces malignancy in laryngeal squamous carcinoma cells. Asian Pac J Cancer Prev, 12, 1785-8.
- Crisponi L, Deiana M, Loi A, et al (2001). The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ ptosis/epicanthus inversus syndrome. Nat Genet, 27, 159-66. https://doi.org/10.1038/84781
- Curtis C, Shah SP, Chin SF, et al (2012). The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature, 486, 346-52.
- Dansen TB, Burgering BM (2008). Unravelling the tumorsuppressive functions of FOXO proteins. Trends Cell Biol, 18, 421-9. https://doi.org/10.1016/j.tcb.2008.07.004
- De BE, Dixon MJ, Small KW, et al (2001). Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotypephenotype correlation. Hum Mol Genet, 10, 1591-600. https://doi.org/10.1093/hmg/10.15.1591
- Dong XY, Chen C, Sun X, et al (2006). FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer. Cancer Res, 66, 6998-7006. https://doi.org/10.1158/0008-5472.CAN-06-0411
- Grasso CS, Wu YM, Robinson DR, et al (2012). The mutational landscape of lethal castration-resistant prostate cancer. Nature, 487, 239-43. https://doi.org/10.1038/nature11125
- Green MR, Aya-Bonilla C, Gandhi MK, et al (2011). Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma. Genes Chromosomes Cancer, 50, 313-26. https://doi.org/10.1002/gcc.20856
- Hannenhalli S, Kaestner KH (2009). The evolution of FOX genes and their role in development and disease. Nat Rev Genet, 10, 233-40.
- Hu X, Stern HM, Ge L, et al (2009). Genetic alterations and oncogenic pathways associated with breast cancer subtypes. Mol Cancer Res, 7, 511-22. https://doi.org/10.1158/1541-7786.MCR-08-0107
- Kaestner KH, Knochel W, Martinez DE (2000). Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev, 14, 142-6.
- Katoh M, Igarashi M, Fukuda H, et al (2013). Cancer genetics and genomics of human FOX family genes. Cancer Lett, 328, 198-206. https://doi.org/10.1016/j.canlet.2012.09.017
- Lehmann OJ, Ebenezer ND, Jordan T, et al (2000). Chromosomal duplication involving the forkhead transcription factor gene FOXC1 causes iris hypoplasia and glaucoma. Am J Hum Genet, 67, 1129-35. https://doi.org/10.1016/S0002-9297(07)62943-7
- Lin L, Miller CT, Contreras JI, et al (2002). The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas. Cancer Res, 62, 5273-9.
- Lokody I (2014). Signalling: FOXM1 and CENPF: co-pilots driving prostate cancer. Nat Rev Cancer, 14, 450-1.
- Mazet F, Yu JK, Liberles DA, et al (2003). Phylogenetic relationships of the FOX (Forkhead) gene family in the Bilateria. Gene, 316, 79-89. https://doi.org/10.1016/S0378-1119(03)00741-8
- Nucera C, Eeckhoute J, Finn S, et al (2009). FOXA1 is a potential oncogene in anaplastic thyroid carcinoma. Clin Cancer Res, 15, 3680-9. https://doi.org/10.1158/1078-0432.CCR-08-3155
- Pohl BS, Knochel W (2005). Of FOX and Frogs: FOX (fork head/ winged helix) transcription factors in Xenopus development. Gene, 344, 21-32. https://doi.org/10.1016/j.gene.2004.09.037
- Sasahira T, Ueda N, Yamamoto K, et al (2014). Prox1 and FOXC2 act as regulators of lymphangiogenesis and angiogenesis in oral squamous cell carcinoma. PLoS One, 9, 92534. https://doi.org/10.1371/journal.pone.0092534
- Schneider J, Ruschhaupt M, Buness A, et al (2006). Identification and meta-analysis of a small gene expression signature for the diagnosis of estrogen receptor status in invasive ductal breast cancer. Int J Cancer, 119, 2974-9. https://doi.org/10.1002/ijc.22234
- Sulman EP, White PS, Brodeur GM (2004). Genomic annotation of the meningioma tumor suppressor locus on chromosome 1p34. Oncogene, 23, 1014-20. https://doi.org/10.1038/sj.onc.1206623
- Tu Q, Brown CT, Davidson EH, et al (2006). Sea urchin Forkhead gene family: phylogeny and embryonic expression. Dev Biol, 300, 49-62. https://doi.org/10.1016/j.ydbio.2006.09.031
- Wijchers PJ, Burbach JP, Smidt MP (2006). In control of biology: of mice, men and FOXes. Biochem J, 397, 233-46. https://doi.org/10.1042/BJ20060387
- Wotton KR, Shimeld SM (2006). Comparative genomics of vertebrate FOX cluster loci. BMC Genomics, 7, 271. https://doi.org/10.1186/1471-2164-7-271
- Xu N, Wu SD, Wang H, et al (2012). Involvement of FOXM1 in non-small cell lung cancer recurrence. Asian Pac J Cancer Prev, 13, 4739-43. https://doi.org/10.7314/APJCP.2012.13.9.4739
- Yang FQ, Yang FP, Li W, et al (2013). FOXl1 inhibits tumor invasion and predicts outcome in human renal cancer. Int J Clin Exp Pathol, 7, 110-22.
- Yu J, Deshmukh H, Payton JE, et al (2011). Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor. Clin Cancer Res, 17, 1924-34. https://doi.org/10.1158/1078-0432.CCR-10-1551
- Zheng CH, Quan Y, Li YY, et al (2014). Expression of transcription factor FOXC2 in cervical cancer and effects of silencing on cervical cancer cell proliferation. Asian Pac J Cancer Prev, 15, 1589-95. https://doi.org/10.7314/APJCP.2014.15.4.1589